2-Deoxy-d-glucose Promotes Buforin IIb-Induced Cytotoxicity in Prostate Cancer DU145 Cells and Xenograft Tumors

Inhibition of the glycolytic pathway is a critical strategy in anticancer therapy because of the role of aerobic glycolysis in cancer cells. The glycolytic inhibitor 2-Deoxy-d-glucose (2-DG) has shown potential in combination with other anticancer agents. Buforin IIb is an effective antimicrobial peptide (AMP) with broad-spectrum anticancer activity and selectivity. The efficacy of combination treatment with 2-DG and buforin IIb in prostate cancer remains unknown. Here, we tested the efficacy of buforin IIb as a mitochondria-targeting AMP in the androgen-independent human prostate cancer cell line DU145. Combining 2-DG with buforin IIb had a synergistic toxic effect on DU145 cells and mouse xenograft tumors. Combination treatment with 2-DG and buforin IIb caused stronger proliferation inhibition, greater G1 cell cycle arrest, and higher apoptosis than either treatment alone. Combination treatment dramatically decreased L-lactate production and intracellular ATP levels, indicating severe inhibition of glycolysis and ATP production. Flow cytometry and confocal laser scanning microscopy results indicate that 2-DG may increase buforin IIb uptake by DU145 cells, thereby increasing the mitochondria-targeting capacity of buforin IIb. This may partly explain the effect of combination treatment on enhancing buforin IIb-induced apoptosis. Consistently, 2-DG increased mitochondrial dysfunction and upregulated Bax/Bcl-2, promoting cytochrome c release to initiate procaspase 3 cleavage induced by buforin IIb. These results suggest that 2-DG sensitizes prostate cancer DU145 cells to buforin IIb. Moreover, combination treatment caused minimal hemolysis and cytotoxicity to normal WPMY-1 cells. Collectively, the current study demonstrates that dual targeting of glycolysis and mitochondria by 2-DG and buforin IIb may be an effective anticancer strategy for the treatment of some advanced prostate cancer.     

The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal forms of human cancer, characterized by unrestrained progression, invasiveness and treatment resistance. To date, there are limited curative options, with surgical resection as the only effective strategy, hence the urgent need to discover novel therapies. A platform of onco-immunology targets is represented by molecules that play a role in the reprogrammed cellular metabolism as one hallmark of cancer. Due to the hypoxic tumor microenvironment (TME), PDA cells display an altered glucose metabolism—resulting in its increased uptake—and a higher glycolytic rate, which leads to lactate accumulation and them acting as fuel for cancer cells. The consequent acidification of the TME results in immunosuppression, which impairs the antitumor immunity. This review analyzes the genetic background and the emerging glycolytic enzymes that are involved in tumor progression, development and metastasis, and how this represents feasible therapeutic targets to counteract PDA. In particular, as the overexpressed or mutated glycolytic enzymes stimulate both humoral and cellular immune responses, we will discuss their possible exploitation as immunological targets in anti-PDA therapeutic strategies.     

Cancer cell metabolism: implications for therapeutic targets

Cancer cell metabolism is characterized by an enhanced uptake and utilization of glucose, a phenomenon known as the Warburg effect. The persistent activation of aerobic glycolysis in cancer cells can be linked to activation of oncogenes or loss of tumor suppressors, thereby fundamentally advancing cancer progression. In this respect, inhibition of glycolytic capacity may contribute to an anticancer effect on malignant cells. Understanding the mechanisms of aerobic glycolysis may present a new basis for cancer treatment. Accordingly, interrupting lactate fermentation and/or other cancer-promoting metabolic sites may provide a promising strategy to halt tumor development. In this review, we will discuss dysregulated and reprogrammed cancer metabolism followed by clinical relevance of the metabolic enzymes, such as hexokinase, phosphofructokinase, pyruvate kinase M2, lactate dehydrogenase, pyruvate dehydrogenase kinase and glutaminase. The proper intervention of these metabolic sites may provide a therapeutic advantage that can help overcome resistance to chemotherapy or radiotherapy.     

Organocatalytic depolymerization of poly(ethylene terephthalate)

We describe the organocatalytic depolymerization of poly(ethylene terephthalate) (PET), using a commercially available guanidine catalyst, 1,5,7‐triazabicyclo[4.4.0]dec‐5‐ene (TBD). Postconsumer PET beverage bottles were used and processed with 1.0 mol % (0.7 wt %) of TBD and excess amount of ethylene glycol (EG) at 190 °C for 3.5 hours under atmospheric pressure to give bis(2‐hydroxyethyl) terephthalate (BHET) in 78% isolated yield. The catalyst efficiency was comparable to other metal acetate/alkoxide catalysts that are commonly used for depolymerization of PET. The BHET content in the glycolysis product was subject to the reagent loading. This catalyst influenced the rate of the depolymerization as well as the effective process temperature. We also demonstrated the recycling of the catalyst and the excess EG for more than 5 cycles. Computational and experimental studies showed that both TBD and EG activate PET through hydrogen bond formation/activation to facilitate this reaction. © 2011 Wiley Periodicals, Inc. J Polym Sci Part A: Polym Chem, 2011     

Synchronization of the Glycolysis Reaction-Diffusion Model via Linear Control Law

The Selkov system, which is typically employed to model glycolysis phenomena, unveils some rich dynamics and some other complex formations in biochemical reactions. In the present work, the synchronization problem of the glycolysis reaction-diffusion model is handled and examined. In addition, a novel convenient control law is designed in a linear form and, on the other hand, the stability of the associated error system is demonstrated through utilizing a suitable Lyapunov function. To illustrate the applicability of the proposed schemes, several numerical simulations are performed in one- and two-spatial dimensions.     

Synthesis of triblock copolymers from glycolysed poly(ethylene terephthalate) by living radical polymerization

Valorization of poly(ethylene terephthalate) (PET) waste has been achieved using glycolysis. The resulting diols were employed for the synthesis of triblock copolymers by atom transfer radical polymerization using copper (I) bromide and (1,1,4,7,10,10)‐hexamethyltriethylenetetramine as catalyst system. Macroinitiator was obtained after depolymerization of PET waste followed by functionalization of the obtained glycolysate with 2‐bromoisobutyrate bromide. Polymerization of styrene (S) and glycidyl methacrylate (GMA) has been achieved leading to PS‐b‐PETG‐b‐PS and (PS‐stat‐PGMA)‐b‐PETG‐b‐(PS‐stat‐PGMA) triblock copolymers. Best results were obtained at 100 °C. At this temperature, termination reaction were negligible and the measured number‐average molar mass of the product increased linearly with monomer conversion in agreement with the theoretical M_n with low polydispersity products achieved. Polymers were also characterized by ¹H NMR. This work presents a original valorization of PET waste as (PS‐stat‐PGMA)‐b‐PETG‐b‐(PS‐stat‐PGMA) copolymer could be used as heat curable coatings. © 2007 Wiley Periodicals, Inc. J Polym Sci Part A: Polym Chem 46: 433–443, 2008     

通过调控肿瘤代谢增强T细胞抗肿瘤活性

肿瘤免疫治疗是一种新型的癌症治疗方法。 然而,现阶段肿瘤免疫疗法的临床响应率低等问题严重制约了其进一步应用。 其根本原因在于肿瘤组织免疫抑制微环境限制了T细胞的抗肿瘤活性,而肿瘤组织代谢改变在肿瘤免疫抑制微环境形成过程中起关键作用。 本文重点总结了通过调控肿瘤的有氧糖酵解、氨基酸代谢和脂肪酸代谢增强T细胞的抗肿瘤活性。 最后,提出当前肿瘤代谢调控研究方面仍然存在的问题,并对纳米载体在肿瘤代谢领域的发展前景进行了展望。     

Micellization and Adsorption Parameters of Nonionic Polymeric Surfactants from Poly(ethylene terephthalate) Waste

Poly (ethylene terephthalate), PET, waste was recycled to oligomers in the presence of triethanolamine and manganese acetate as a catalyst. The produced oligomers were reacted with stearic acid and polyethylene glycol having different molecular weights 400, 1000, and 4000 to produce nonionic polymeric surfactants having different hydrophile‐hydrophobe balances (HLB). The surface tension, critical micelle concentration (CMC) and surface activities were determined at different temperatures. Surface parameters such as, surface excess concentration Γ_max, the area per molecule at interface A_min and the effectiveness of surface tension reduction (Π_CMC) were determined from the adsorption isotherms of the prepared surfactants. Some thermodynamic data for the adsorption process are calculated and discussed.     

Surface and Thermodynamic Parameters of Polymeric Surfactants from Recycled Poly(ethylene terephthalate)

Recycling of PET waste was carried out in presence of diethanolamine and manganese acetate as catalyst. The produced oligomers were reacted with stearic acid and polyethylene glycol, PEG, which have different molecular weights 400, 1,000, and 4,000 to produce nonionic polymeric surfactants having different hydrophilic‐hydrophobic balance (HLB). The surface tension, critical micelle concentration (CMC), and surface activities were determined at different temperatures. Surface parameters such as surface excess concentration Γ_max, the area per molecule at interface A_min and the effectiveness of surface tension reduction (Π_CMC) were determined from the adsorption isotherms of the prepared surfactants. From the adsorption isotherm, some thermodynamic data for the adsorption process are calculated and discussed.     

A new Belousov-Zhabotinsky reaction with fructose 1,6-bisphosphate as the organic substrate

The effects of temperature, free radicals, chloride and bromide ions, and bromine on the Belousov-Zhabotinsky reaction with fructose 1,6-bisphosphate were studied. The apparent activation energies of the induction period, lifetime, and oscillation period were found to be 76.24, 101.29, and 62.93 kJ mol⁻¹, respectively. Published in Russian in Izvestiya Akademii Nauk. Seriya Khimicheskaya, No. 5, pp. 906–908, May, 2006.